We are live on ! Find out more
YIH

Y-Intercept (HK) Portfolio holdings

AUM $5.05B
1-Year Est. Return 17.89%
This Fund
S&P 500
This Quarter Est. Return
-3.59%
1 Year Est. Return
+17.89%
3 Year Est. Return
+34.37%
5 Year Est. Return
+20.59%
10 Year Est. Return
AUM
$437M
AUM Growth
+$15.8M
Cap. Flow
+$23.7M
Cap. Flow %
5.41%
Top 10 Hldgs %
9.97%
Holding
1,022
New
478
Increased
104
Reduced
117
Closed
322

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$7.25M
2
ZBH icon
Zimmer Biomet
ZBH
+$3.96M
3
DHI icon
D.R. Horton
DHI
+$3.94M
4
AAL icon
American Airlines Group
AAL
+$3.89M
5
O icon
Realty Income
O
+$3.66M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 14.18%
2 Financials 13.02%
3 Healthcare 11.76%
4 Technology 11.36%
5 Industrials 11.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ICUI icon
476
ICU Medical
ICUI
$4.2B
$280K 0.06%
+1,256
New +$281K
WH icon
477
Wyndham Hotels & Resorts
WH
$5.6B
$280K 0.06%
3,311
+785
+31% +$66.8K
BTI icon
478
British American Tobacco
BTI
$136B
$278K 0.06%
6,592
-97,760
-94% -$4.17M
FSR
479
DELISTED
Fisker Inc.
FSR
$278K 0.06%
+21,580
New +$270K
CBRL icon
480
Cracker Barrel
CBRL
$1.23B
$277K 0.06%
+2,332
New +$289K
XM
481
DELISTED
Qualtrics International Inc. Class A Common Stock
XM
$277K 0.06%
+9,701
New +$280K
TRN icon
482
Trinity Industries
TRN
$2.99B
$275K 0.06%
8,005
+1,264
+19% +$38.9K
AGL icon
483
Agilon Health
AGL
$1.65B
$274K 0.06%
432
-109
-20% -$56.2K
MRVI icon
484
Maravai LifeSciences
MRVI
$1.02B
$274K 0.06%
+7,755
New +$260K
SPTM icon
485
State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
$13.5B
$274K 0.06%
+4,934
New +$271K
ITB icon
486
iShares US Home Construction ETF
ITB
$2.36B
$273K 0.06%
+4,604
New +$315K
AUB icon
487
Atlantic Union Bankshares
AUB
$6.1B
$272K 0.06%
+7,413
New +$296K
DIS icon
488
Walt Disney
DIS
$172B
$272K 0.06%
+1,980
New +$286K
SHO icon
489
Sunstone Hotel Investors
SHO
$2.2B
$272K 0.06%
+23,129
New +$263K
CXM icon
490
Sprinklr
CXM
$1.5B
$270K 0.06%
+22,720
New +$274K
PINC
491
DELISTED
Premier
PINC
$270K 0.06%
7,587
+1,808
+31% +$67.3K
CHPT icon
492
ChargePoint
CHPT
$139M
$269K 0.06%
+678
New +$209K
AMX icon
493
America Movil
AMX
$75.9B
$268K 0.06%
+12,670
New +$245K
OLLI icon
494
Ollie's Bargain Outlet
OLLI
$4.16B
$268K 0.06%
+6,236
New +$278K
AFG icon
495
American Financial Group
AFG
$12B
$267K 0.06%
+1,835
New +$250K
PBR.A icon
496
Petrobras Class A
PBR.A
$106B
$267K 0.06%
19,082
-54,411
-74% -$669K
SHCR
497
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
$267K 0.06%
+108,250
New +$356K
VYM icon
498
Vanguard High Dividend Yield ETF
VYM
$81.8B
$266K 0.06%
2,373
-450
-16% -$50.2K
ITCI
499
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$266K 0.06%
4,349
-923
-18% -$47.9K
CORT icon
500
Corcept Therapeutics
CORT
$10.2B
$265K 0.06%
+11,782
New +$251K

Similar funds

Y-Intercept (HK)'s Q1 2022 Portfolio in Review

As of Q1 2022, Y-Intercept (HK) held 1,022 positions worth $437M, up 3.7% from $421M the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Y-Intercept (HK) deployed $23.7M of net new capital in Q1 2022, opening 478 new positions and adding to 104 existing holdings. Its largest new stake was Linde: 23,465 shares worth $7.5M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 14% of assets, up from 10% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Apple, an estimated $18.8M trimmed.

  • Y-Intercept (HK)'s largest Q1 2022 buy was Linde: 23,465 shares worth $7.5M.
  • Y-Intercept (HK) added most to Realty Income in Q1 2022, an estimated $3.66M increase.
  • Y-Intercept (HK)'s biggest Q1 2022 reduction was Apple, cutting an estimated $18.8M.
  • Y-Intercept (HK) fully exited Berkshire Hathaway Class B in Q1 2022, selling an estimated $5.55M.
  • Y-Intercept (HK)'s ten largest holdings make up 10% of its $437M portfolio in Q1 2022.
  • Y-Intercept (HK) opened 478 new positions and closed 322 in Q1 2022.
  • Y-Intercept (HK)'s portfolio value rose 3.7% quarter-over-quarter to $437M.

Based on Y-Intercept (HK)'s 13F filing for Q1 2022, filed 16 May 2022.